* All sessions will be presented in English.
| Day 1 (May 29. 2026, Fri) | |||||
|---|---|---|---|---|---|
| TIME | Room 1 | Room 2 | Room 3 | Park Studio | Studio 8-10 |
| 08:00-08:30 | Registration | ||||
| 08:30-09:50 | Session 01 Oral Presentation Competition I |
Session 02 [기초] Inflammation as the Common Soil of CKM Syndrome |
Session 03 [운동/생활습관] Emerging Lifestyle Strategies in Cardiometabolic Care |
||
| 09:50-10:00 | Break | ||||
| 10:00-11:20 | Session 04 Obesity-related HFpEF and Metabolic Cardiomyopathy |
Session 05 AI & Digital Health for Management of CKM |
Session 06 KSCMS/KSN Joint Session Kidney at the Heart of CKM: The Renal Driver of CKM Syndrome |
||
| 11:20-11:30 | Break | ||||
| 11:30-11:40 | Opening Ceremony | ||||
| 11:40-11:50 | Scientific Report | ||||
| 11:50-12:00 | Break | ||||
| 12:00-12:30 |
Satellite Symposium: Luncheon Session I 
|
Satellite Symposium: Luncheon Session II 
|
Satellite Symposium: Luncheon Session III 
|
||
| 12:30-13:00 | Intermission and Coffee Break | ||||
| 13:00-13:30 | Plenary Lecture I The Changing Landscape of Heart Failure: Integrating Genetics, Inflammation, and Metabolism |
||||
| 13:30-14:00 | Plenary Lecture II Visualizing the Invisible: AI and the Future of Cardiometabolic Risk Assessment |
||||
| 14:00-14:10 | Break | ||||
| 14:10-15:10 | Session 07 The CKM-AF Link: Is the Atrium a Victim or a Driver? |
Session 08 Press Conference (기자간담회) |
Session 09 [Committee Session] Next Generation |
Mini-Oral (14:10-15:10) |
Moderated Poster (14:10-15:10) |
| 15:10-15:30 | Break | ||||
| 15:30-17:00 | Session 10 Keynote Lecture Session I |
Session 11 Dietary Strategies in CKM Syndrome: Moving Beyond Caloric Restriction (15:30-16:50) |
|||
| 17:00-17:20 | Break | Break (16:50-17:20) | |||
| 17:20-18:40 | Session 12 KSCMS/JSH Joint Session Synergistic Approaches to Hypertension and CKM Syndrome: A Joint Initiative |
Session 13 Next-Generation Incretin Therapeutics: Impact on Metabolic Disease Management |
Session 14 Holistic Care: A Multidimensional Approach to Obesity |
||
| 19:00-20:30 | Faculty Dinner | ||||
* All sessions will be presented in English.
| Day 2 (May 30. 2026, Sat) | |||||
|---|---|---|---|---|---|
| TIME | Room 1 | Room 2 | Room 3 | Park Studio | Studio 8-10 |
| 07:30-08:00 | Satellite Symposium: Breakfast Session Ⅰ |
Satellite Symposium: Breakfast Session II |
Satellite Symposium: Breakfast Session III |
||
| 08:00-08:30 | Registration and Break | ||||
| 08:30-09:50 | Session 15 KSCMS/IAS Joint Session Targeting Residual Risk in Atherosclerotic CVD |
Session 16 Obesity and Cardiometabolic Disease: From Molecular Mechanisms to Clinical Practice |
Session 17 Inflammation in CKM Syndrome: From Pathophysiology to Clinical Risk |
||
| 09:50-10:00 | Break | ||||
| 10:00-10:30 | Presidential Lecture | ||||
| 10:30-11:00 | Plenary Lecture III FH Masterclass: Cracking the Code of Long-term Treatment Adherence |
||||
| 11:00-11:30 |
Plenary Lecture IV Why Not Stick to the Guidelines?: A Call to Action |
||||
| 11:30-11:40 | Break | ||||
| 11:40-11:50 | General Assembly | ||||
| 11:50-12:00 | Break | ||||
| 12:00-12:30 | Satellite Symposium: Luncheon Session IV |
Satellite Symposium: Luncheon Session V |
Satellite Symposium: Luncheon Session VI |
||
| 12:30-13:00 | Intermission and Coffee Break | ||||
| 13:00-15:00 | |||||
| Session 18 Keynote Lecture Session II |
Session 19 Unraveling the Bone-Muscle-Fat Axis in the Era of CKML Syndrome (13:00-14:20) |
||||
| Break (14:20-14:30) | |||||
| Session 20 Oral Presentation Competition II (14:30-15:30) |
Mini-Oral II (14:30-15:30) |
Moderated Poster II (14:30-15:30) |
|||
| 15:00-15:40 | Break | ||||
| Break (15:30-15:40) | |||||
| 15:40-17:00 | Session 21 KSCMS/OCC Joint Session Convergence of Cardiometabolic Science: New Paradigms in Integrated Therapy |
Session 22 RNA Revolution: Silencing the Drivers of CKM Syndrome |
Session 23 Deep Dive into Clinical Obesity |
||
| 17:00-17:10 | Break | ||||
| 17:10-18:10 | Session 24 Distinguished Young Investigator Award Session |
Session 25 Young Investigator Award Session |
Session 26 Unresolved Questions in Dyslipidemia Management: Complex Clinical Scenarios |
||
| 18:10-18:20 | Intermission | ||||
| 18:20-18:50 | Closing and Award Ceremony | ||||